|
Volumn 14, Issue 10, 2007, Pages 23-25
|
Antipsychotics: Pharmacology and clinical decision making
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
ARIPIPRAZOLE;
CHLORPROMAZINE;
CLOZAPINE;
DOPAMINE 2 RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
HISTAMINE H1 RECEPTOR ANTAGONIST;
MUSCARINIC RECEPTOR BLOCKING AGENT;
NEUROLEPTIC AGENT;
OLANZAPINE;
PARTIAL AGONIST;
QUETIAPINE;
RISPERIDONE;
SEROTONIN 1A RECEPTOR;
SEROTONIN 2A ANTAGONIST;
SEROTONIN 2A RECEPTOR;
SEROTONIN 2C ANTAGONIST;
ZIPRASIDONE;
BLURRED VISION;
CLINICAL DECISION MAKING;
CLINICAL PHARMACOLOGY;
COGNITIVE DEFECT;
CONSTIPATION;
DIZZINESS;
DRUG MECHANISM;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
HYPERPROLACTINEMIA;
HYPOTENSION;
POLYPHARMACY;
POSITRON EMISSION TOMOGRAPHY;
PSYCHOSIS;
RECEPTOR AFFINITY;
SATIETY;;
SCHIZOPHRENIA;
SEDATION;
SHORT SURVEY;
SIDE EFFECT;
TACHYCARDIA;
TARDIVE DYSKINESIA;
URINE RETENTION;
WEIGHT GAIN;
XEROSTOMIA;
|
EID: 35549011075
PISSN: 10826319
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (3)
|
References (8)
|